A Targeted Drug combination for patients suffering from an ovarian cancer type can be nearly twice as effective as the next-best treatment, according to preliminary results from a Phase II study. Researchers opine that these results, which happen to be presented at the 2023 American Society of Clinical Oncology annual meeting, will go on to […]

The post Targeted Drug Mix For Ovarian Cancer Cases Twice Effective first appeared on World Pharma Today.